- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Metabolic modeling-based drug repurposing in Glioblastoma ; volume:12 ; number:1 ; day:1 ; month:7 ; year:2022 ; pages:1-13 ; date:12.2022
Scientific reports ; 12, Heft 1 (1.7.2022), 1-13, 12.2022
- Creator
-
Tomi-Andrino, Claudio
Pandele, Alina
Winzer, Klaus
King, John
Rahman, Ruman
Kim, Dong-Hyun
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-022-14721-w
- URN
-
urn:nbn:de:101:1-2022082122272283981126
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:34 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tomi-Andrino, Claudio
- Pandele, Alina
- Winzer, Klaus
- King, John
- Rahman, Ruman
- Kim, Dong-Hyun
- SpringerLink (Online service)
Other Objects (12)
Drug repurposing for the treatment of glioblastoma multiforme
From GWAS to drug screening: repurposing antipsychotics for glioblastoma
Drug repurposing
Repurposing metabolic regulators: antidiabetic drugs as anticancer agents
Drug repurposing using transcriptome sequencing and virtual drug screening in a patient with glioblastoma
Drug repurposing using transcriptome sequencing and virtual drug screening in a patient with glioblastoma
Drug repurposing in cardiology
Drug Repurposing in Oncology
Tumor Treating Fields (TTFields) combined with the drug repurposing approach CUSP9v3 induce metabolic reprogramming and synergistic anti-glioblastoma activity in vitro
Repurposing FDA-approved drugs as inhibitors of therapy-induced invadopodia activity in glioblastoma cells
Drug repurposing with network reinforcement
Repurposing of approved cardiovascular drugs
Drug repurposing for the treatment of glioblastoma multiforme
From GWAS to drug screening: repurposing antipsychotics for glioblastoma
Drug repurposing
Repurposing metabolic regulators: antidiabetic drugs as anticancer agents
Drug repurposing using transcriptome sequencing and virtual drug screening in a patient with glioblastoma
Drug repurposing using transcriptome sequencing and virtual drug screening in a patient with glioblastoma
Drug repurposing in cardiology
Drug Repurposing in Oncology
Tumor Treating Fields (TTFields) combined with the drug repurposing approach CUSP9v3 induce metabolic reprogramming and synergistic anti-glioblastoma activity in vitro
Repurposing FDA-approved drugs as inhibitors of therapy-induced invadopodia activity in glioblastoma cells
Drug repurposing with network reinforcement
Repurposing of approved cardiovascular drugs
Drug repurposing for the treatment of glioblastoma multiforme
From GWAS to drug screening: repurposing antipsychotics for glioblastoma
Drug repurposing
Repurposing metabolic regulators: antidiabetic drugs as anticancer agents
Drug repurposing using transcriptome sequencing and virtual drug screening in a patient with glioblastoma
Drug repurposing using transcriptome sequencing and virtual drug screening in a patient with glioblastoma
Drug repurposing in cardiology
Drug Repurposing in Oncology
Tumor Treating Fields (TTFields) combined with the drug repurposing approach CUSP9v3 induce metabolic reprogramming and synergistic anti-glioblastoma activity in vitro
Repurposing FDA-approved drugs as inhibitors of therapy-induced invadopodia activity in glioblastoma cells
Drug repurposing with network reinforcement